Gwyer D, Wragg NM, Wilson SL
In dermatology research, double-blind clinical trials have demonstrated that GHK-Cu cream applied for 12 weeks produced a 70% improvement in skin laxity, 35% increase in procollagen synthesis, and measurable increases in dermal thickness (Finkley et al., 2005)
BPC-157 is not FDA-approved for human use , and we currently lack large, high-quality human clinical trials proving its effectiveness
However, as with any experimental treatment, potential risks and side effects may exist
This method is not FDA-approved and can be risky
The Blunt Truth About Lipo C and Weight Loss Here's the honest answer: Lipo C injections are not a weight loss drug